Nikko Asset Management Americas Inc. lessened its holdings in Invitae Co. (NYSE:NVTA – Get Rating) by 0.1% in the 4th quarter, Holdings Channel.com reports. The fund owned 17,256,161 shares of the medical research company’s stock after selling 19,190 shares during the period. Nikko Asset Management Americas Inc. owned approximately 0.07% of Invitae worth $32,096,000 as […]
Invitae Co. (NYSE:NVTA – Get Rating) has been given a consensus rating of “Hold” by the twelve research firms that are presently covering the company, Marketbeat.com reports. Five analysts have rated the stock with a sell recommendation and five have assigned a hold recommendation to the company. The average 1-year price objective among analysts that […]
Swiss National Bank increased its holdings in Invitae Co. (NYSE:NVTA – Get Rating) by 4.5% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 539,600 shares of the medical research company’s stock after buying an additional 23,100 shares during […]
Mirae Asset Global Investments Co. Ltd. decreased its position in shares of Invitae Co. (NYSE:NVTA – Get Rating) by 21.7% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,415,682 shares of the medical research company’s stock after selling 391,747 shares during the period. […]
StockNews.com initiated coverage on shares of Invitae (NYSE:NVTA – Get Rating) in a research note issued to investors on Thursday morning. The brokerage issued a sell rating on the medical research company’s stock. Several other research analysts also recently issued reports on NVTA. The Goldman Sachs Group downgraded shares of Invitae from a neutral rating […]